Embryome Sciences, Inc. Acquires Exclusive License for Advanced Cell Technology 'ACTCellerate' Technology

Published: Jul 16, 2008

ALAMEDA, Calif.--(BUSINESS WIRE)--Embryome Sciences, Inc., a wholly owned subsidiary of BioTime, Inc., (OTCBB:BTIM) has acquired from Advanced Cell Technology, Inc. (“ACT”) an exclusive license to use “ACTCellerate™” embryonic stem cell technology and a bank of over 140 diverse progenitor cell lines derived using that technology.

Back to news